//
Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Randomized Placebo-Controlled Trial
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure
Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction
A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report
Functional Impairment and Medication Burden in Adults With Heart Failure
Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection Fraction
Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis